Evaluation of dose differences between intracavitary applicators for cervical brachytherapy using knowledge-based models

被引:3
|
作者
Kallis, Karoline [1 ]
Mayadev, Jyoti [1 ]
Covele, Brent [1 ]
Brown, Derek [1 ]
Scanderbeg, Daniel [1 ]
Simon, Aaron [1 ]
Frisbie-Firsching, Helena [1 ]
Yashar, Catheryn M. [1 ]
Einck, John P. [1 ]
Mell, Loren K. [1 ]
Moore, Kevin L. [1 ]
Meyers, Sandra M. [1 ]
机构
[1] Univ Calif San Diego, Dept Radiat Med & Appl Sci, San Diego, CA 92103 USA
基金
美国医疗保健研究与质量局; 美国国家卫生研究院;
关键词
Knowledge-based planning; Dose prediction; Cervical cancer; Intracavitary brachytherapy; Tandem and ovoids; Tandem and ring; HDR-BRACHYTHERAPY; CANCER BRACHYTHERAPY; RADIATION-THERAPY; WORKING GROUP; OPTIMIZATION; TANDEM; ALGORITHM; ANATOMY; QUALITY; RING;
D O I
10.1016/j.brachy.2021.08.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: Currently, there is a lack of patient-specific tools to guide brachytherapy planning and applicator choice for cervical cancer. The purpose of this study is to evaluate the accuracy of organ-at-risk (OAR) dose predictions using knowledge-based intracavitary models, and the use of these models and clinical data to determine the dosimetric differences of tandem-and-ring (T&R) and tandem-and-ovoids (T&O) applicators. MATERIALS AND METHODS: Knowledge-based models, which predict organ D-2cc, were trained on 77/75 cases and validated on 32/38 for T&R/T&O applicators. Model performance was quantified using Delta D-2cc=D-2cc,D-actual-D-2cc,D-predicted, with standard deviation (sigma(AD(2cc))) representing precision. Model-predicted applicator dose differences were determined by applying T&O models to T&R cases, and vice versa, and compared to clinically-achieved D2cc differences. Applicator differences were assessed using a Student's t-test (p < 0.05 significant). RESULTS: Validation T&O/T&R model precision was 0.65/0.55 Gy, 0.55/0.38 Gy, and 0.43/0.60 Gy for bladder, rectum and sigmoid, respectively, and similar to training. When applying T&O/T&R models to T&R/T&O cases, bladder, rectum and sigmoid D-2cc values in EQD2 were on average 5.69/2.62 Gy, 7.31/6.15 Gy and 3.65/0.69 Gy lower for T&R, with similar HRCTV volume and coverage. Clinical data also showed lower T&R OAR doses, with mean EQD2 D-2cc deviations of 0.61 Gy, 7.96 Gy (p < 0.01) and 5.86 Gy ( p < 0.01) for bladder, rectum and sigmoid. CONCLUSIONS: Accurate knowledge-based dose prediction models were developed for two common intracavitary applicators. These models could be beneficial for standardizing and improving the quality of brachytherapy plans. Both models and clinical data suggest that significant OAR sparing can be achieved with T&R over T&O applicators, particularly for the rectum. (C) 2021 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1323 / 1333
页数:11
相关论文
共 50 条
  • [1] A knowledge-based organ dose prediction tool for brachytherapy treatment planning of patients with cervical cancer
    Yusufaly, Tahir, I
    Kallis, Karoline
    Simon, Aaron
    Mayadev, Jyoti
    Yashar, Catheryn M.
    Einck, John P.
    Mell, Loren K.
    Brown, Derek
    Scanderbeg, Daniel
    Hild, Sebastian J.
    Covele, Brent
    Moore, Kevin L.
    Meyers, Sandra M.
    BRACHYTHERAPY, 2020, 19 (05) : 624 - 634
  • [2] Knowledge-based dose prediction models to inform gynecologic brachytherapy needle supplementation for locally advanced cervical cancer
    Kallis, Karoline
    Mayadev, Jyoti
    Kisling, Kelly
    Brown, Derek
    Scanderbeg, Daniel
    Ray, Xenia
    Cortes, Katherina
    Simon, Aaron
    Yashar, Catheryn M.
    Einck, John P.
    Mell, Loren K.
    Moore, Kevin L.
    Meyers, Sandra M.
    BRACHYTHERAPY, 2021, 20 (06) : 1187 - 1199
  • [3] MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer
    Jurgenliemk-Schulz, Ina M.
    Tersteeg, Robbert J. H. A.
    Roesink, Judith M.
    Bijmolt, Stefan
    Nomden, Christel N.
    Moerland, Marinus A.
    de Leeuw, Astrid A. C.
    RADIOTHERAPY AND ONCOLOGY, 2009, 93 (02) : 322 - 330
  • [4] Comparison of dose volume parameters evaluated using three forward planning - optimization techniques in cervical cancer brachytherapy involving two applicators
    Chakrobarti, Bikramjit
    Basu-Roy, Somapriya
    Kar, Sanjay Kumar
    Das, Sounik
    Lahiri, Annesha
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2017, 9 (05) : 431 - 445
  • [5] Improving plan quality in cervical cancer brachytherapy using knowledge-based planning for direction modulated brachytherapy tandem applicator
    Gautam, Suman
    Flower, Emily
    Richeson, Dylan
    Sangha, Ikchit
    Ma, Tianjun
    Song, William Y.
    BRACHYTHERAPY, 2025, 24 (01) : 144 - 153
  • [6] Attention 3D UNET for dose distribution prediction of high-dose-rate brachytherapy of cervical cancer: Intracavitary applicators
    Gautam, Suman
    Osman, Alexander F. I.
    Richeson, Dylan
    Gholami, Somayeh
    Manandhar, Binod
    Alam, Sharmin
    Song, William Y.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2025, 26 (02):
  • [7] Evaluation of variation in dose of organs at risk in intracavitary brachytherapy of cervical cancer - a prospective study
    Sharma, Brahmacharimayum Arunkumar
    Singh, Tomcha
    Singh, L. Jaichand
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2011, 3 (01) : 23 - 25
  • [8] Dosimetric comparison of two different applicators and rectal retraction methods used in inverse optimization-based intracavitary brachytherapy for cervical cancer
    Biltekin, Fatih
    Gultekin, Melis
    Yilmaz, Melek Tugce
    Yildiz, Ferah
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (01) : 35 - 43
  • [9] Comparison of dose delivered to vagina using two different intracavitary brachytherapy applicators for carcinoma cervix
    Bajwa, Harjot Kaur
    Talluri, Anil Kumar
    Maqbool, Aijaz
    Reddy, Devender
    Singareddy, Rohith
    Sresty, N. V. N. Madhusudhana
    Raju, Alluri Krishnam
    BRACHYTHERAPY, 2022, 21 (02) : 151 - 157
  • [10] CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer
    Murakami, Naoya
    Kasamatsu, Takahiro
    Wakita, Akihisa
    Nakamura, Satoshi
    Okamoto, Hiroyoki
    Inaba, Koji
    Morota, Madoka
    Ito, Yoshinori
    Sumi, Minako
    Itami, Jun
    BMC CANCER, 2014, 14